Literature DB >> 14706644

Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse.

Yoshiko Takano1, Hiroshi Ohguro, Mari Dezawa, Hiroto Ishikawa, Hitoshi Yamazaki, Ikuyo Ohguro, Kazuhisa Mamiya, Tomomi Metoki, Futoshi Ishikawa, Mitsuru Nakazawa.   

Abstract

In the present study, we studied drug effects of Ca(2+) antagonists on the retinal degeneration of rd mouse to evaluate their efficacy. Several kinds of Ca(2+) antagonists, diltiazem, nicardipine, nilvadipine or nifedipine were administrated intraperitoneally and thereafter retinal morphology and functions were analyzed. In addition, we performed DNA microarray analysis both in nilvadipine treated and control retinas to understand their drug effects at molecular levels. We found that nilvadipine caused significant preservation of retinal thickness in rd mouse during the initial stage of the retinal degeneration, and nicardipine showed also significant but lesser preservation than nilvadipine. However, we recognized no preservation effects of diltiazem and nifedipine. In the total 3774 genes, the expressions of 27 genes were altered upon administration of nilvadipine, including several genes related to the apoptotic pathway, neuro-survival factor, Ca(2+) metabolisms, and other mechanisms. It is suggested that some types of Ca(2+) channel blockers, such as nilvadipine and nicardipine, are able to preserve photoreceptor cells in rd mouse and can potentially be used to treat some RP patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14706644     DOI: 10.1016/j.bbrc.2003.12.034

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

Review 1.  Do calcium channel blockers rescue dying photoreceptors in the Pde6b ( rd1 ) mouse?

Authors:  Peter Barabas; Carolee Cutler Peck; David Krizaj
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy.

Authors:  Agnieszka Magrys; Thimmappa Anekonda; Gaoying Ren; Grazyna Adamus
Journal:  J Clin Immunol       Date:  2007-01-19       Impact factor: 8.317

3.  Silencing of tuberin enhances photoreceptor survival and function in a preclinical model of retinitis pigmentosa (an american ophthalmological society thesis).

Authors:  Stephen H Tsang; Lawrence Chan; Yi-Ting Tsai; Wen-Hsuan Wu; Chun-Wei Hsu; Jin Yang; Joaquin Tosi; Katherine J Wert; Richard J Davis; Vinit B Mahajan
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

4.  Broad spectrum metabolomics for detection of abnormal metabolic pathways in a mouse model for retinitis pigmentosa.

Authors:  Ellen R Weiss; Shoji Osawa; Yubin Xiong; Suraj Dhungana; James Carlson; Susan McRitchie; Timothy R Fennell
Journal:  Exp Eye Res       Date:  2019-03-16       Impact factor: 3.467

Review 5.  Potential neuroprotective biomolecules in ophthalmology.

Authors:  Mehrdad Afarid; Fatemeh Sanie-Jahromi
Journal:  Int Ophthalmol       Date:  2020-11-12       Impact factor: 2.031

6.  Blood-to-Retina Transport of Fluorescence-Labeled Verapamil at the Blood-Retinal Barrier.

Authors:  Yoshiyuki Kubo; Ayumi Nakazawa; Shin-Ichi Akanuma; Ken-Ichi Hosoya
Journal:  Pharm Res       Date:  2018-03-12       Impact factor: 4.200

7.  The selective estrogen receptor modulator raloxifene mitigates the effect of all-trans-retinal toxicity in photoreceptor degeneration.

Authors:  Tamar Getter; Susie Suh; Thanh Hoang; James T Handa; Zhiqian Dong; Xiuli Ma; Yuanyuan Chen; Seth Blackshaw; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

Review 8.  Photoreceptor cell death mechanisms in inherited retinal degeneration.

Authors:  Javier Sancho-Pelluz; Blanca Arango-Gonzalez; Stefan Kustermann; Francisco Javier Romero; Theo van Veen; Eberhart Zrenner; Per Ekström; François Paquet-Durand
Journal:  Mol Neurobiol       Date:  2008-11-04       Impact factor: 5.590

9.  Effects of calcium ion, calpains, and calcium channel blockers on retinitis pigmentosa.

Authors:  Mitsuru Nakazawa
Journal:  J Ophthalmol       Date:  2010-12-23       Impact factor: 1.909

Review 10.  The use of canine models of inherited retinal degeneration to test novel therapeutic approaches.

Authors:  William A Beltran
Journal:  Vet Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.